VANDELLI, Carmen
 Distribuzione geografica
Continente #
NA - Nord America 3.018
EU - Europa 1.090
AS - Asia 960
SA - Sud America 127
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.210
Nazione #
US - Stati Uniti d'America 2.995
GB - Regno Unito 358
SG - Singapore 322
CN - Cina 277
SE - Svezia 208
HK - Hong Kong 160
IT - Italia 138
DE - Germania 114
BR - Brasile 102
TR - Turchia 78
VN - Vietnam 74
RU - Federazione Russa 60
UA - Ucraina 59
FI - Finlandia 47
BG - Bulgaria 26
NL - Olanda 19
FR - Francia 13
BE - Belgio 12
AR - Argentina 11
CA - Canada 11
KR - Corea 10
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
IE - Irlanda 7
PL - Polonia 7
EC - Ecuador 6
IN - India 6
ID - Indonesia 5
MX - Messico 5
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
AT - Austria 3
IL - Israele 3
JP - Giappone 3
LT - Lituania 3
AL - Albania 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
GD - Grenada 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
UZ - Uzbekistan 1
Totale 5.210
Città #
Santa Clara 315
Fairfield 284
Ashburn 250
Southend 229
Woodbridge 222
Chandler 198
Singapore 179
Houston 176
Hong Kong 160
Ann Arbor 127
Wilmington 127
Jacksonville 120
Nyköping 97
Dearborn 89
Seattle 85
Chicago 81
Cambridge 78
Los Angeles 73
London 63
Beijing 55
Hefei 50
Izmir 50
Salt Lake City 36
Moscow 32
San Diego 32
Princeton 30
New York 26
Sofia 26
Des Moines 25
Eugene 25
Ho Chi Minh City 25
Hanoi 23
Shanghai 20
Boardman 19
Helsinki 19
Munich 19
Dallas 17
Modena 17
Buffalo 16
Amsterdam 13
São Paulo 12
Brussels 11
Lancaster 11
Sterling 11
Tampa 11
The Dalles 10
Frankfurt am Main 9
Reggio Nell'emilia 9
Falls Church 8
Seoul 8
Dublin 7
Elk Grove Village 7
Milan 7
Brooklyn 6
Guangzhou 6
Redwood City 6
San Mateo 6
Bologna 5
Bremen 5
Johannesburg 5
Miami 5
Phoenix 5
Warsaw 5
Xi'an 5
Auburn Hills 4
Brno 4
Detroit 4
Groningen 4
Jersey City 4
Kansas City 4
Kunming 4
Norwalk 4
Porto Alegre 4
Rio de Janeiro 4
Toronto 4
Turku 4
Ankara 3
Atlanta 3
Augusta 3
Brasília 3
Council Bluffs 3
Da Nang 3
Denver 3
Goiânia 3
Grafing 3
Guayaquil 3
Hải Dương 3
Kilburn 3
Olomouc 3
Ottawa 3
Phủ Lý 3
Quito 3
Redondo Beach 3
Wuhan 3
Americana 2
Anshun 2
Belo Horizonte 2
Biên Hòa 2
Boston 2
Busto Arsizio 2
Totale 3.822
Nome #
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study 303
Genetic polymorphisms of interleukin-6 modulates fibrosis progression in mild chronic hepatitis C. 278
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naive hepatitis C patients. 270
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 264
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 262
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 259
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study 234
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 222
Chronic hepatitis C and psychosocial distress 220
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 216
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” Study. 215
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008. 204
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy 197
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 184
Analysis of factors involved in fibrosis progression among hepatitis C virus carriers with normal alanine aminotransferares. 41st Annual Meeting of the European Association for the Study of the Liver (EASL).Vienna, Austria, 26-30 Aprile 2006. 176
Long-term interferon therapy in patients with refractory chronic hepatitis C: effect on histological liver damage and hepatocellular carcinogenesis. 174
Health-related quality of life in recent and long standing chronic HCV infection. 169
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 169
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” 169
Hepatitis C virus carriers with normal alanine aminotransferases: analysis of factors involved in fibrosis progression. 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Barcellona, Spagna, 11-15 aprile 2007. 167
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). 155
The virologic and histologic status in anti HCV+ve subjects with normal ALT levels: results of a ten year prospective follow-up study. 154
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 154
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD). San Francisco, 31 Ottobre- 4 Novembre 2008. 153
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD) 149
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano, Italia, 23-27 Aprile, 2008. 118
Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C 2
Totale 5.237
Categoria #
all - tutte 20.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 43 90 67 21 57 43 35
2021/2022476 9 58 50 59 13 24 26 13 56 34 90 44
2022/2023526 61 68 36 46 63 92 3 52 84 2 11 8
2023/2024318 8 21 14 32 49 19 52 79 6 2 11 25
2024/20251.035 36 13 7 137 221 150 60 32 136 46 71 126
2025/2026928 85 53 95 211 448 36 0 0 0 0 0 0
Totale 5.237